Back to Search Start Over

Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.

Authors :
de Lemos JA
Morrow DA
Source :
Reviews in cardiovascular medicine [Rev Cardiovasc Med] 2003; Vol. 4 Suppl 4, pp. S37-46.
Publication Year :
2003

Abstract

Management of patients with acute coronary syndromes (ACS) is becoming more complex as the array of treatment options available to patients and physicians continues to expand. Cardiac biomarkers play an important role in risk stratification in ACS, and results of cardiac biomarker tests can be used to help guide choices between alternative therapies. In addition to biomarkers of myocyte necrosis, markers of neurohormonal activation, such as B-type natriuretic peptide (BNP), provide important prognostic information in ACS. In the future, multimarker strategies that incorporate panels of cardiac biomarkers are likely to be used for risk stratification and for pathophysiology-guided treatment in patients with ACS.

Details

Language :
English
ISSN :
1530-6550
Volume :
4 Suppl 4
Database :
MEDLINE
Journal :
Reviews in cardiovascular medicine
Publication Type :
Academic Journal
Accession number :
14564227